Key Event Details
- The Hon'ble National Company Law Tribunal (NCLT), Mumbai Bench, approved the acquisition of Genrx Pharmaceuticals Private Limited (in Liquidation) on a going concern basis
- Order date: October 13, 2026
- The company downloaded the order from the NCLT official website on October 13, 2026
- This disclosure is in continuation of earlier disclosures dated April 5, 2025 and April 7, 2025 regarding the acquisition
Financial and Operational Impact
- Genrx Pharmaceuticals Private Limited will become a Wholly Owned Subsidiary of Bajaj Healthcare Limited
- The implementation is subject to the terms specified in the NCLT order
- No expected financial implications quantified in the disclosure
- No penalties or restrictions imposed by the authority
- No aberrations/non-compliances identified by the authority
Effective Period
The order is effective from October 13, 2026 until any further order(s) or directions issued by the Hon'ble National Company Law Tribunal.
Company Action
The Company shall take necessary actions in accordance with the terms of the NCLT order.
Additional Information
- No other relevant information provided
- No financial quantification of the acquisition provided in this disclosure